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Primary small cell carcinoma of larynx is a rare tumor representing less than 0.5% of all laryngeal cancers. This is one of the
most lethal of all malignancies associated with frequent early widespread metastases and dismal prognosis. We report a case of a
60-year-old patient with small cell carcinoma of the subglottic larynx, who presented with hepatic metastasis.
1.Introduction
Primary laryngeal carcinomas comprise approximately 2%
to 5% of all malignancies worldwide. Of these laryngeal
carcinomas, approximately 99% are primary squamous cell
carcinomas [1]. First reported in 1972, the primary small cell
carcinoma of larynx is a rare tumor representing less than
0.5% of all laryngeal cancers [2]. This is one of the most
lethal of malignancies associated with frequent and early
widespread metastases and dismal prognosis [3]. During the
past30years,about160casesofprimarysmallcellcarcinoma
of the larynx have been reported worldwide [1]. Most of
the patients are between 50 to 70 years of age [1]. Men are
more commonly aﬀected [2]. It has been associated with
heavy smoking [2]. Symptoms are similar to those associated
with other laryngeal carcinomas. Because of its nonspeciﬁc
clinical and radiological manifestations, the diagnosis of
small cell carcinoma of the larynx is essentially based on the
light microscopic examination aided by electron microscopy
or immunohistochemical staining [4]. Primary small cell
carcinoma of the larynx continues to pose problems in its
treatment. Two- and 5-year survival have been reported to
be 16 and 5%, respectively [2]. The only variables, which
signiﬁcantly aﬀect survival, are the presence of metastases at
initial examination and treatment modality. No association
has been found with the stage of the disease [5].
2.CaseSummary
A 60-year-old male reported with the complaints of throat
pain and hoarseness of voice for 3 months. The patient had
been smoking 2 packs of cigarette per day for the past 25
years. Direct laryngoscopy revealed a 2cm growth below
the vocal cords. Contrast Enhanced Computed Tomography
(CECT) of neck showed growth in subglottic region, and
CECT thorax and abdomen showed multiple hypodense
lesions in both the lobes of liver suggestive of metastasis
(Figure 1).
Abiopsywastakenfromthelesion,andhistopathological
examination revealed small round cells with scant amount of
cytoplasm and hyperchromatic nuclei suggestive of a round
cell tumor (Figure 2).
Immunohistochemistry (IHC) examination showed that
the tumor cells were positive for synaptophysin (Figure 3)
and cytokeratin. CD-20, CD-3, and LCA were negative. So
the diagnosis of small cell carcinoma was made.
The patient was given palliative external radiotherapy
i nad o s eo f2 0 G yi nﬁ v ef r a c t i o n so v e ro n ew e e k .A f t e r
the completion of radiotherapy the patient was given com-
bination chemotherapy with cisplatin and etoposide. The
general condition of the patient improved initially with
therapy and he remained asymptomatic with disease for
almost 10 months after which he developed bone pains.2 Case Reports in Oncological Medicine
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Figure 1: CT scan of the patient showing the primary tumor in the subglottic region.
Figure 2: Photomicrograph showing sheets of small round cells
with a scant amount of cytoplasm and hyperchromatic nuclei.
(H&E; ×200.).
A radioisotope bone scan revealed multiple skeletal metas-
tases. The general condition of the patient was too poor to
tolerate any chemotherapy. He was oﬀered best supportive
Figure 3: Photomicrograph showing tumor cells positive for syn-
aptophysin.
care but he succumbed to his disease 12 months after
diagnosis.Case Reports in Oncological Medicine 3
3. Discussion
The WHO has characterized neuroendocrine tumor of the
larynx into four types: typical carcinoid tumor, atypical
carcinoid tumor, small-cell neuroendocrine tumor, and par-
aganglioma [6]. An accurate histologic diagnosis is essential
because the treatment and prognosis depends on the type
of neuroendocrine tumor [6]. Small cell neuroendocrine
neoplasm of the larynx has the worst prognosis, with ﬁve-
year survival rates of 5% [7]. Commonly, cervical and
distant metastases are seen at the time of diagnosis [2,
7]. The treatment of small cell carcinoma of the larynx
remains controversial as small number of patients has been
reported in the literature and there is lack of controlled
studies. The aggressive nature of small cell carcinoma of the
larynx presents a challenge to the oncologist [8]. Reports
of improved survival with systemic chemotherapy combined
with radiation therapy had been suggested as a primary
treatment modality for laryngeal small cell carcinoma [9].
Cisplatin, etoposide, cyclophosphamide, doxorubicin, vin-
cristine, and methotrexate have been the most commonly
used chemotherapeutic agents [7, 9]. Longer survival has
been observed in patients who receive chemotherapy [1, 9,
10]. In the present case, the patient was given radiotherapy
for palliation of local symptoms followed by systemic chem-
otherapy with cisplatin and etoposide combination, which
improved the general condition of the patient for nearly ten
monthsandthepatientsurvivedforayeardespitepresenting
with metastatic disease. Recent reports also suggest that
surgery is not indicated, and radiation therapy and systemic
chemotherapy appear to be the least disabling and the most
eﬃc a c i o u sf o r mo ft r e a t m e n tf o rt h es m a l lc e l lc a r c i n o m ao f
the larynx [6, 10]. Surgery is best reserved for persistent and
recurrent disease at the primary site and neck [9].
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